... Hsa-miR-101-1 Antiviral therapy Herpes simplex virus type 1 (HSV-1), now known as Human alphaherpesvirus 1 , is a linear double-stranded DNA virus that infects humans [ 1 ]. The HSV infects primarily mucous cells and establishes latent infections in nerve cells, and recurrences are common...

.... Hepatitis B virus Human immunodeficiency virus Co-infection Antiviral therapy Drug-resistant mutations Prevalence Chronic hepatitis B virus (HBV) infection remains a major global public health problem, with there being about 240 million hepatitis B surface antigen (HBsAg) carriers worldwide [ 1...

... 3a individuals. Methods: The patients were given antiviral therapy with IFN-α-2b, 3 million units 3 times a week and 800-1,200 mg of ribavirin daily adjusted to the patient's body weight (<60 kg 800 mg day− 1 , and >60 kg 1,200 day− 1 ). The patients received this combination therapy for 24...

... to in the content or advertisements. Hepatitis B Hepatitis B virus chronic carrier Hepatitis B virus DNA Hepatitis B virus infectivity Healthcare providers Mother-to-child transmission Antiviral therapy Entecavir Tenofovir Telbivudine Hepatitis B virus (HBV) is almost exclusively produced...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hepatitis B virus Antiviral therapy...

...Bruno Roche; Didier Samuel Antiviral therapy using newer nucleos(t)ide analogues with lower resistance rates such as entecavir or tenofovir could suppress hepatitis B virus (HBV) replication, improve liver function, delay or obviate the need for liver transplantation in some patients, and reduce...

... is indicated for mild acute hepatitis B; however, antiviral therapy should be initiated for patients showing signs of significant liver impairment as exemplified by deterioration of prothrombin time to an equivalent of 1.5 or 50% of the ‘Quick test'. For fulminant hepatitis, there is no complete agreement...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. AIDS Antiviral therapy HIV Sir, Data emerging from clinical studies also indicate that the initiation of treatment during primary HIV...

...-resistant HBV strains do exist in treatment-naïve individuals in this region. Further studies are essential to characterize the role of HBVrt amino acid substitutions in response to anti-HBV therapy. Antiviral therapy Mutation Drug resistance Genotypes Hepatitis B virus Reverse transcriptase...

... cytomegalovirus Antiviral therapy New drugs Intervirology Intervirology 1997:40:357-367 Jens-Uwe Vogel Jindrich Cinatl, Jr. Institut für Medizinische Virologie, Johann Wolfgang Goethe-Universität, Frankfurt am Main, Deutschland Treatment of Cytomegalovirus Diseases Key Words Human cytomegalovirus Antiviral...

... Antigenemia Immunocompromised patients Renal transplant recipients Congenital infection Antiviral therapy © 1996 S. Karger AG, Basel 1996 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized...

... when therapy was discontinued (after 3 weeks), an equivalent incidence and level of viremia were established rapidly in both ddC-treated and control cats. The FeLV model, therefore, can be used to assess rapidly experimental single agent or combined antiviral therapies for persistent retrovirus...

.... Mutations develop in about a quarter of the patients on lamivudine therapy, mostly downstream to the MHR. They may contribute to non-response to the antiviral therapy. 15 07 2004 23 05 2005 23 1 2006 © 2006 S. Karger AG, Basel 2006 Copyright / Drug Dosage / Disclaimer Copyright...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cytomegalovirus Leflunomide Antiviral therapy Endothelial cells Fibroblasts Part II. Diagnostics and Antiviral...

... antiviral efficacy in clinical trials with a sustained inhibition of viral replication. However, due to the kinetics of viral clearance, long-term antiviral therapy is necessary to eradicate viral infection. These prolonged regimens are associated with the emergence of drug-resistant strains that harbor...